Lung cancer treatments fall into three main categories: chemotherapy, targeted therapy, and immunotherapy. Each approach uses a different mechanism to attack cancer cells, and the best option depends on the type and stage of lung cancer as well as specific genetic markers in the tumor. A recent report from Cure Today explains how these treatments work and when they are used.

Key Takeaways

  • Chemotherapy kills rapidly dividing cells, including cancer cells, throughout the body.
  • Targeted therapy focuses on specific genetic mutations found in some lung cancer cells.
  • Immunotherapy helps the body’s own immune system recognize and attack cancer cells.
  • Treatment choice often depends on biomarker testing of the tumor.
  • Side effects vary by treatment type and can be managed with supportive care.

How Chemotherapy Works for Lung Cancer

Chemotherapy uses drugs that travel through the bloodstream to reach cancer cells throughout the body. These drugs target cells that divide quickly, which is a hallmark of cancer. Normal cells that also divide quickly, such as those in the bone marrow, digestive tract, and hair follicles, can be affected as well, leading to common side effects like fatigue, nausea, and hair loss.

In lung cancer, chemotherapy is often used for advanced stages or when the cancer has spread. It can be given before surgery to shrink tumors or after surgery to kill remaining cancer cells. According to the original report, chemotherapy remains a standard treatment for many patients, especially those whose tumors do not have targetable mutations.

How Targeted Therapy Works

Targeted therapy is designed to interfere with specific molecules that drive cancer growth. In lung cancer, this often means drugs that target mutations in genes such as EGFR, ALK, or ROS1. These mutations are found in a subset of non-small cell lung cancer (NSCLC) cases, particularly in people who have never smoked or have a family history.

Unlike chemotherapy, targeted therapy works more precisely on cancer cells that carry the mutation, which can lead to fewer side effects. Patients must undergo biomarker testing to determine if their tumor has a targetable mutation. The original report emphasizes that targeted therapy can be highly effective but may lose effectiveness over time if the cancer develops resistance.

How Immunotherapy Works

Immunotherapy helps the immune system recognize and destroy cancer cells. Some lung cancers produce proteins that hide them from immune cells. Immunotherapy drugs called immune checkpoint inhibitors block these proteins, allowing T cells to attack the tumor.

These drugs are often used for advanced NSCLC after standard treatments have failed, or as a first-line treatment in some cases. The original report notes that immunotherapy can produce durable responses but also carries a risk of immune-related side effects, such as inflammation in the lungs, colon, or skin.

Choosing the Right Lung Cancer Treatment

The choice of treatment depends on several factors. First, doctors determine the type of lung cancer: small cell or non-small cell. Biomarker testing of the tumor identifies mutations that may be targeted by specific drugs. The stage of cancer and the patient’s overall health also play a role.

Sometimes treatments are combined. For example, chemotherapy may be given with immunotherapy to improve effectiveness. Clinical trials continue to explore new combinations and sequences. The original report advises patients to discuss all options with their oncology team.

Frequently Asked Questions

What are the most common side effects of lung cancer treatments?

Side effects depend on the treatment. Chemotherapy often causes fatigue, nausea, hair loss, and increased infection risk. Targeted therapy can cause rash, diarrhea, or liver problems. Immunotherapy may lead to inflammation in organs such as the lungs, skin, or colon. Most side effects are manageable with medications and supportive care.

Can lung cancer treatments cure the disease?

In some cases, especially when lung cancer is caught early and treated with surgery or chemoradiation, cure is possible. For advanced stages, treatments like targeted therapy and immunotherapy can control the disease for years, but a cure is less common. The original report stresses that survival outcomes have improved significantly with newer therapies.

How long does each type of lung cancer treatment last?

Chemotherapy is often given in cycles over 3 to 6 months. Targeted therapy is usually taken daily as a pill for as long as it works, sometimes years. Immunotherapy is given as an infusion every few weeks, often for up to two years if the patient responds well. Duration varies based on individual response and tolerance.

This article is based on a report from Cure Today published via Google News. Consult your healthcare provider for personalized medical advice.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.